SUMMARY
PIKfyve enzymatic activity is required in maintaining late endocytic membrane integrity. PIKfyve is a dual-specificity enzyme that phosphorylates phosphatidylinositol (PtdIns) and PtdIns 3-P at the 5-hydroxyl and unidentified endogenous protein substrate(s). To distinguish between which of these activities (lipid versus protein kinase activity) is responsible for endomembrane homeostasis we analyzed a double mutant PIKfyve K1999/2000E . These substitutions in the putative lipid-substrate activation loop nearly completely abrogated the lipid kinase activity without any significant effect on the protein kinase activity of PIKfyve K1999/2000E .
Expression of PIKfyve K1999/2000E in COS cells induced a dramatic dominant-negative effect in the form of endomembrane swelling and vacuolation. In addition, the lipidsubstrate specificity of PIKfyve was modified by introducing single mutations in Lys1999 or Lys2000. This yielded proteins with preferentially abrogated synthesis of PtdIns 5-P (PIKfyve K2000E ) or PtdIns 3,5-P 2 (PIKfyve K1999E ), of which only the PIKfyve K1999E mutant induced the characteristic endomembrane defects upon cell transfection. Furthermore, phosphoinositide microinjection into cells demonstrated a selective ability of PtdIns 3,5-P 2 to correct the endomembrane defects induced by the dominant-negative PIKfyve lipid kinase-deficient mutants. Thus, PtdIns 3,5-P 2 production by PIKfyve is crucial for endomembrane integrity and Lys1999 most likely directs the PIKfyve interactions with the 3-phosphate group in PtdIns 3-P.
In eukaryotic cells complex control mechanisms operate to ensure the temporal and spatial regulation of intracellular membrane trafficking pathways (for a recent review see Ref. 1) . Although the primary role of proteins in the trafficking events is indisputable, multiple studies indicate that lipids, in particular the highly phosphorylated metabolites of phosphatidylinositol (PtdIns) 1 , collectively called phosphoinositides (PI) also play a fundamental role in this process (for recent reviews see Refs. [2] [3] [4] . This has been first demonstrated by genetic studies of protein transport to the yeast vacuole (or lysosome in higher cells). One of the required genes, VPS34 appeared to be a PI 3-kinase that specifically phosphorylates PtdIns at position D-3 of the inositol ring to produce PtdIns 3-P (5). Subsequent genetic and biochemical studies both in yeast and mammalian cells have uncovered that many lipid kinases and phosphatases, presumably through generating specific PI signals are important in several cellular membrane transport processes such as clathrinmediated endocytosis, GLUT4 vesicle translocation, formation of MVBs, autophagy, phagocytosis, micropinocytosis and biosynthetic trafficking events (2-4).
It should be emphasized that most of our knowledge related to the functions of PIs is based on studies involving stimulation and/or inactivation of the lipid kinases/phosphatases that produce them. To fully understand the roles of PIs and to obtain mechanistic insight in the context of live cells, specific cellular changes elicited by particular PI molecular species must be documented. Because the cell membrane is impermeable to these anionic lipids, direct demonstration that a specific PI functions as an effector in a cellular context was illustrated in only few instances (6) (7) (8) (9) . Data based on lipid-derived studies are critical because of two reasons. First, in a cellular membrane micro-environment, a complex of factors such as substrate availability, accessibility and presentation, or enzyme regulation may affect the lipid substrate specificity, making the identity of the final PI effector unclear. Second, most members of the PIK family, including PI 3-Ks, PI 4-Ks and PI 5-Ks, are now found to display a dual specificity, i.e., act as both lipid and protein kinases (10) . Physiologically relevant protein substrates and potential roles of these protein kinase activities in cellular regulation are still unknown for the majority of the dual specificity kinases. However, recent studies in which the lipid and protein kinase activities of PI 3-K have functionally been separated (11) clearly demonstrated distinct signals triggering different cellular functions.
PIKfyve, a mammalian phosphoinositide 5-kinase containing a Fyve finger domain (12) is one of the best examples of such a perplexing situation. This kinase was found to display a dual specificity for both lipids and proteins (13) . It is largely localized to MVBs suggesting a role of the phosphorylated products of the PIKfyve enzymatic activity in MVB function (14) . In agreement with this prediction, expression of a kinase-dead point mutant, PIKfyve K1831E , elicited a dramatic dominant-negative phenotype in a form of a progressive accumulation of multiple swollen vacuoles with endocytic origin (15) . Based upon available structural studies of PIPK Type II (16) and PI 3-K (17) , and the conservation of the catalytic machinery between PIP-kinases and protein kinases (18) , Lys1831 was determined as the putative amino acid that binds the -phosphate of ATP. Concordantly, both enzymatic activities were fully eliminated in the dominant-negative PIKfyve K1831E mutant (13) . Furthermore, the PIKfyve lipid kinase activity was found to synthesize two phosphoinositide products, PtdIns 3,5-P 2 and PtdIns 5-P (19) . Thus, although the role of PIKfyve enzymatic activity in maintaining the endocytic membrane homeostasis was unequivocally established, the precise lipid and/or protein product responsible for this function remained to be determined. Therefore to distinguish between the lipid and protein kinase activities we analyzed several PIKfyve mutants that selectively display either one of the two enzymatic activities or altered PIsubstrate specificity. In addition, microinjected PIKfyve lipid products were examined for correcting the intracellular membrane defects induced by the PIKfyve lipid kinase-deficient mutants. In this paper we demonstrate that PtdIns 3,5-P 2 production is essential for endomembrane homeostasis. 
EXPERIMENTAL PROCEDURE

Constructs and fusion proteins--
Immunoprecipitation, Immunoblotting, Lipid and Protein Kinase assays
Forty eight hours posttransfection COS-7 cells, transiently transfected with HAepitope-tagged PIKfyve S constructs in either pCMV5 or pEGFP expression vectors, were lysed in RIPA buffer (50 mM Tris/HCl, pH 8.0, containing 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate and 1x protease inhibitor cocktail). Lysates were immunoprecipitated with rabbit anti-HA polyclonal antibodies (kind gift from Mike Czech) that quantitatively immunoprecipitated HA-tagged PIKfyve as described elsewhere (13) . Anti-HA-immunoprecipitates were immobilized on Protein ASepharose CL-4B beads and used in both protein and lipid kinase assays as described (13, 19 (Whatman, PE SIL G, 250 µm) and separated by the acidic solvent system as described previously (19) . Generated radioactive products were detected by autoradiography and quantified by radioactive counting of the silica scrapings.
RESULTS AND DISCUSSION
In the absence of a resolved crystal structure of the PIKfyve catalytic domain, we compared the primary amino acid sequence of the PIKfyve-related proteins with the available structural characteristics of the PtdIns-3-P binding site within the FYVE finger domain in human EEA1 protein (20 was shown to have no detectable lipid kinase activity (13) . As expected, PIKfyve WT displayed functional lipid kinase activity and synthesized PtdIns 5-P and PtdIns 3,5-P 2 from native PtdIns at a ratio 1:2.3 (Fig. 1A, lane 2) . The lipid kinase activity of PIKfyve K1999/2000E was dramatically reduced (Fig. 1A, lane 4) although not fully eliminated as with the PIKfyve K1831E kinase-defective mutant (Fig. 1A, lane 3) . At longer exposure times, a relatively small amounts of PtdIns 5-P and PtdIns 3,5-P 2 were detected. This corresponded to 9 + 1% and 4 + 0.2% (n=3) of the PtdIns 5-P and PtdIns 3,5-P 2 levels, respectively, produced by PIKfyve WT at a similar level of protein overexpression (Fig. 1B) . We next examined the ability of the double mutant to act as a protein kinase by monitoring the rate of its autophosphorylation activity.
Importantly, whereas the lipid kinase activity of PIKfyve K1999/2000E was largely abrogated, its protein kinase activity was identical to that of PIKfyve WT (Fig. 1C and   D ). Consistent with our previous studies, lack of any detectable protein kinase activity was observed for the PIKfyve K1831E mutant at expression levels equal to or higher than PIKfyve WT (Fig. 1B and C) . Importantly, examination of GFP-based HAconstructs showed protein and lipid kinase activities indistinguishable from the corresponding HA-tagged constructs, confirming that GFP-addition at the Nterminus of HA-PIKfyve did not alter the activity (Fig. 1D) PIKfyve K1999E and PIKfyve K2000E were generated in pCMV5 vector and used to transfect COS-7 cells. Expression of the PIKfyve proteins with expected size of ~200 kDa was confirmed by SDS-PAGE and Western blotting (Fig. 1B, lanes 5 and 6) .
Similarly to the PIKfyve K1999/2000E double mutant, the two point mutants displayed protein kinase activity at a level and rate similar to that of the wild type (Fig. 1C , lanes 5 and 6, Fig. 1D and not shown). However, analysis of their in vitro lipid kinase activity showed a markedly different pattern. The PIKfyve K1999E mutant displayed significantly compromised PtdIns 3,5-P 2 production, resulting in only 11 + 0.8% of that produced by PIKfyve WT . Conversely, the PtdIns 5-P production by this mutant was only reduced to 40 + 3% compared to that of the wild type protein (Fig.   1A and Fig. 3A and B) . The exact opposite functional activities were observed with PIKfyve K2000E mutant. This mutant displayed largely compromised PtdIns 5-P synthesis while PtdIns 3,5-P 2 production was much less affected ( Fig. 1A and Fig. 3A and B). These data strongly suggest that Lys1999 is involved in the ligation of the 3-phosphate in PtdIns 3-P while Lys2000 serves to ligate the 1-phosphate in both
PtdIns and PtdIns 3-P substrates. Hence, mutation in position 1999 results in a protein that still binds and converts a PtdIns substrate but is hardly effective with PtdIns 3-P. In contrast, the PIKfyve K2000E mutant can more efficiently utilize PtdIns 3-P as a substrate than PtdIns.
We therefore determined whether this altered lipid-substrate specificity of the point mutants was associated with manifestation of a different cell phenotype. The pEGFP version of these mutants together with PIKfyve WT , PIKfyve K1831E and PIKfyve K1999/2000E were transiently expressed in COS cells. Transfected cells were examined relatively to the PIKfyve K1831E mutant for the appearance of the characteristic cell vacuolation phenotype between 10 and 48 hours posttransfection by fluorescence and phase-contrast microscopy. As illustrated in Fig. 2c and d (Fig. 2) . These include a 15-h post-transfection period of the vacuole appearance, honeycomb shape, and 2-3 giant vacuoles in some cases comprising the majority of the cell volume. Quantitation of vacuolation potency of the mutants as well as their relative ability for PtdIns 3,5-P 2 or PtdIns 5-P production from three independent experiments is shown in Fig. 3 . These results demonstrate a correlation between the appearance of endomembrane defects/cytoplasmic vacuoles and the mutant's attenuated ability for PtdIns 3,5-P 2 rather than for PtdIns 5-P production. Together, these results infer that PtdIns 3,5-P 2 but not PtdIns 5-P is the essential downstream mediator of the PIKfyve enzymatic activity in maintaining endomembrane
homeostasis.
To further demonstrate a direct functional role of PtdIns 3,5-P 2 we introduced shrunk ~20 h after the lipid administration in practically all treated cells (Fig. 4a-c) .
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